Literature DB >> 9691361

Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels.

M Stucki1, J Schnorf, H Hustinx, H Gerber, P G Lerch, A Halabi, C H Kleinbloesem, A Morell.   

Abstract

Properties of a new anti-D immunoglobulin were assessed in Rh(D) negative healthy male adults. Six volunteers received intravenous, and five volunteers intramuscular injections of 200 micrograms anti-D, 48 hours after pre-treatment with 5 mL of Rh(D) positive erythrocytes. Immediately after intravenous administration of anti-D, a rapid decrease of the Rh(D) positive erythroyctes was noted. After intramuscular injection of anti-D, there was a lag phase of 6 hours until the erythrocytes decreased, and the elimination rate was slower. Twenty-four hours after injection of anti-D, the Rh(D) positive erythrocytes were at the detection limit or no longer detectable in all volunteers. After intravenous administration, anti-D serum levels decreased from 45 ng/mL at 2 hours to 29 ng/mL at 24 hours, whereas after intramuscular administration, anti-D became detectable at 4 hours and increased to 11 ng/mL at 24 hours. During subsequent months, anti-D serum levels decreased at similar rates in both groups. After six months, anti-D was not detectable in any of the volunteers. Thus, the new anti-D immunoglobulin induced elimination of the Rh(D) positive erythrocytes and suggested that Rh(D) immunization of the volunteers was prevented.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691361     DOI: 10.1016/S1246-7820(98)80409-6

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  1 in total

1.  Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.

Authors:  Sean R Stowell; C Maridith Arthur; Kathryn R Girard-Pierce; Harold C Sullivan; Manjula Santhanakrishnan; Prabitha Natarajan; Seema R Patel; Christopher A Tormey; James C Zimring; Jeanne E Hendrickson
Journal:  Haematologica       Date:  2015-07-16       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.